Efficacy and Safety Evaluation of Immune Checkpoint Inhibitors in Combination With Chemotherapy for Extensive Small Cell Lung Cancer: Real‐World Evidence
The primary distinction between these treatments was observed in the management of patients with brain metastasis. The literature lacks comparative studies on the effects of first-line ICI treatment on the central nervous system, rendering our findings significant in clinical practice. Despite the retrospective nature of this study and the potential for various biases, we recommend the preferential use of Atezo + CE in patients with brain metastasis to potentially enhance prognosis.
Authors
- Hiroshige Yoshioka (ORCID: https://orcid.org/0000-0001-7724-0481)
- Yukiko Okuno (ORCID: https://orcid.org/0000-0002-3788-1513)
- Utae Katsushima (ORCID: https://orcid.org/0009-0005-1314-5270)
- Yuta Yamanaka (ORCID: https://orcid.org/0009-0009-7872-4395)
- Yuki Takeyasu (ORCID: https://orcid.org/0000-0003-3295-0273)
- Yuko Sanada
- Takayasu Kurata (ORCID: https://orcid.org/0000-0003-4123-3567)
- Tatsuki Ikoma (ORCID: https://orcid.org/0000-0003-3758-3425)
- Keisuke Kamisako (ORCID: https://orcid.org/0009-0009-9363-0282)
- Yuta Okazaki (ORCID: https://orcid.org/0009-0007-4599-8897)
- Kentaro Nakanishi (ORCID: https://orcid.org/0009-0003-9520-3467)
- K Yoshida
Institutions
- Kansai Medical University (JP)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/cam4.70480
- Citations
- 3
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.85